Our Team

Board of Directors

Rick Doblin, Ph.D., Founder and Executive Director

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

David Bronner, Board of Directors

Independent Voting Member David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, the top-selling brand of natural soaps in North America and producer of a range of organic body care and food products. He is a grandson of company founder, Emanuel Bronner, and a fifth-generation soapmaker. David and Michael established Dr. Bronner’s as a…
Meet David

Staff

Rick Doblin, Ph.D., Founder and Executive Director

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

Kris Lotlikar, President

Kris Lotlikar serves as the President of MAPS, overseeing financing and day-to-day operations globally. Since joining the organization, Kris helped standup MAPS Public Benefit Corporation as a leading psychedelic drug development company and raised over $80 million. Kris’s passion and expertise is in building high-performing organizations in nascent and innovative markets: climate solutions, cannabis, and…
Meet Kris

MAPS Public Benefit Corporation (MAPS PBC)

MAPS Public Benefit Corporation (MAPS PBC) is a Delaware public benefit corporation and a wholly owned subsidiary of MAPS with the special purpose to balance income from legal sales of MDMA with the social benefits of MAPS’ mission.

Board of Directors: MAPS Public Benefit Corporation (MAPS PBC)

Rick Doblin, Ph.D., Founder and Executive Director

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

Staff: MAPS Public Benefit Corporation (MAPS PBC)

Michael Mullette, Chief Operating Officer (MAPS PBC)

Michael Mullette is an experienced drug development and commercialization expert, currently serving as Chief Operating Officer at MAPS Public Benefit Corporation (MAPS PBC). Mullette most recently served as the Vice President and Managing Director of North America for Moderna, where he oversaw commercialization of the company’s COVID-19 vaccine during the height of the pandemic. 
Meet Michael

Berra Yazar-Klosinski, Ph.D., Chief Scientific Officer of the MAPS Public Benefit Corporation

Berra Yazar-Klosinski, Ph.D., is Chief Scientific Officer of the MAPS Public Benefit Corporation (MAPS PBC). Dr. Yazar-Klosinski is responsible for development of strategic, catalytic, and capacity-building activities to facilitate research on the risk/benefit profile of psychedelics in compliance with the global regulatory landscape. She has been actively involved in the various stages of nonclinical and…
Meet Berra